Compare Act I : The AI Prophecy (ACT) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Act I : The AI Prophecy vs Enzyme — how do they compare? Act I : The AI Prophecy trades at Rp168.57 (market cap Rp159,94M, Rp438,74M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Act I : The AI Prophecy is the larger of the two by market cap, and Act I : The AI Prophecy's circulating supply is 948,2M ACT versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Act I : The AI Prophecy for 38 Days and Enzyme for 29 Days on average.
| ACT | MLN | |
|---|---|---|
Market Cap | Rp159,94M | Rp134,13M |
Volume (24h) | Rp438,74M | Rp104,56M |
Circulating Supply | 948,2M ACT | 3,3M MLN |
Typical Hold Time | 38 Days | 29 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Act I : The AI Prophecy
Act I: The AI Prophecy Project (commonly known as Act I) is an open-source, decentralized platform that fosters unique interactions between AI systems. It aims to create an ecosystem where various AI, powered by a specialized token called ACT, can collaborate with each other and human users. Act I seeks to redefine traditional AI chatbots by emphasizing creativity over the standard “helpful, harmless, and honest” principles. By enabling collaboration between different types of AI, such as text and image generators, Act I strives to advance the development of more sophisticated AI technologies.
Read more on ACT →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
